Quote:
Originally Posted by Tupelo3
Two.companies, which we have discussed here before, are trying to do this. Affirms AG and Prothena are both researching A-Syn vaccines to attempt to reduce the levels in PD patients. They both have the goal of slowing, or halting, PD progression by reducing the amount of misfolded or mutated A-Syn. Early results have been very encouraging.
|
Thanks. I see they have both passed phase I/safety studies are are hoping to start phase 2 soon.